Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Podocyte Sphingolipid Signaling in Nephrotic Syndrome. | Cell Physiol Biochem | 2021 | 33861526 | PubTator, text mining | PubMed |
| In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer. | Sci Rep | 2021 | 33850183 | PubTator, text mining | PubMed |
| Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes. | Front Endocrinol (Lausanne) | 2021 | 33815291 | PubTator, text mining | PubMed |
| Melanin Distribution in Human Skin: Influence of Cytoskeletal, Polarity, and Centrosome-Related Machinery of Stratum basale Keratinocytes. | Int J Mol Sci | 2021 | 33808676 | PubTator, text mining | PubMed |
| Shiga Toxins: An Update on Host Factors and Biomedical Applications. | Toxins (Basel) | 2021 | 33803852 | PubTator, text mining | PubMed |
| Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease. | Elife | 2021 | 33769280 | PubTator, text mining | PubMed |
| Grouper Interferon-Induced Transmembrane Protein 1 Inhibits Iridovirus and Nodavirus Replication by Regulating Virus Entry and Host Lipid Metabolism. | Front Immunol | 2021 | 33767703 | PubTator, text mining | PubMed |
| Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease. | Nat Metab | 2021 | 33758422 | PubTator, text mining | PubMed |
| Transcriptome analysis of sinensetin-treated liver cancer cells guided by biological network analysis. | Oncol Lett | 2021 | 33747212 | PubTator, text mining | PubMed |
| Neutral sphingomyelinase-2 and cardiometabolic diseases. | Obes Rev | 2021 | 33738905 | PubTator, text mining | PubMed |
| Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34- and immature CD34+ cells. | Sci Rep | 2021 | 33731863 | PubTator, text mining | PubMed |
| Stage-Specific De Novo Synthesis of Very-Long-Chain Dihydroceramides Confers Dormancy to Entamoeba Parasites. | mSphere | 2021 | 33731470 | PubTator, text mining | PubMed |
| Clinical analysis of 13 children with primary hyperoxaluria type 1. | Urolithiasis | 2021 | 33721035 | PubTator, text mining | PubMed |
| The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications. | Front Immunol | 2021 | 33717150 | PubTator, text mining | PubMed |
| AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies. | Trends Mol Med | 2021 | 33714697 | PubTator, text mining | PubMed |
| Medical evaluation and pharmacotherapeutical strategies in management of urolithiasis. | Ther Adv Urol | 2021 | 33708261 | PubTator, text mining | PubMed |
| A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome. | BMC Nephrol | 2021 | 33691640 | PubTator, text mining | PubMed |
β-Sitosterol 3-O-D-glucoside increases ceramide levels in the stratum corneum via the up-regulated expression of ceramide synthase-3 and glucosylceramide synthase in a reconstructed human epidermal keratinization model. | PLoS One | 2021 | 33684145 | PubTator, text mining | PubMed |
| Integrated Network and Gene Ontology Analysis Identifies Key Genes and Pathways for Coronary Artery Diseases. | Avicenna J Med Biotechnol | 2021 | 33680369 | PubTator, text mining | PubMed |
| ORMDL3 Functions as a Negative Regulator of Antigen-Mediated Mast Cell Activation via an ATF6-UPR-Autophagy-Dependent Pathway. | Front Immunol | 2021 | 33679742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=53